3 terminated, 2 completed. 2 Not applicable, 2 Phase 2, 1 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Terminated 1 |
| Phase 2 | 2 | Completed 1, Terminated 1 |
| Phase 1 | 1 | Terminated 1 |
Follow Stage IVA Hypopharyngeal Squamous Cell Carcinoma: new trials by email Literature Review of Stage IVA Hypopharyngeal Squamous Cell Carcinoma trials Research Report on Stage IVA Hypopharyngeal Squamous Cell Carcinoma
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Nivolumab, Carboplatin, and Paclitaxel in Treating Patients With Stage III-IV Head and Neck Squamous Cell Carcinoma That Can Be Removed by Surgery Paclitaxel, Carboplatin, Nivolumab - Name Human Papillomavirus Positive Oropharyngeal Squamous Cell Carcinoma, Stage II Oropharyngeal Squamous Cell Carcinoma | Phase 2 | Completed | Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University | 34 | 2017-11-13 | 2025-04-24 |
| Prepare to Care, A Supported Self-Management Intervention for Head and Neck Cancer CaregiversHead and Neck Cancer Communication Intervention, Watch video, Module completion of the Prepare to Care kit - Caregiver, Malignant Head and Neck Neoplasm | Not applicable | Completed | Wake Forest University Health Sciences | 35 | 2017-05-15 | 2023-01-09 |
| Stereotactic Body Radiation Therapy in Treating Patients With High Risk Locally Advanced Head and Neck Cancer Stereotactic Body Radiation Therapy, Positron Emission Tomography, Computed Tomography - Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma | Not applicable | Terminated | Case Comprehensive Cancer Center | 3 | 2015-03-03 | 2019-01-24 |
| Ganetespib Window of Opportunity Study in Head and Neck Cancers Ganetespib, Therapeutic Conventional Surgery, Laboratory Biomarker Analysis - Stage I Hypopharyngeal Squamous Cell Carcinoma, Stage I Laryngeal Squamous Cell Carcinoma | Phase 1 | Terminated | Emory University | 3 | 2014-12-01 | 2016-07-26 |
| Capecitabine and Vorinostat in Treating Patients With Recurrent and/or Metastatic Head and Neck Cancer Capecitabine, Vorinostat - Paranasal Sinus Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma | Phase 2 | Terminated | National Cancer Institute (NCI) | 25 | 2010-12-01 | 2017-04-14 |
Squamous Cell Carcinoma of Head and Neck (5) · Head and Neck Neoplasms (1) · Lymphoid Interstitial Pneumonia (1)
Carcinoma (5) · Carcinoma, Squamous Cell (5) · Neoplasms (5) · Neoplasms by Histologic Type (5) · Neoplasms by Site (5) · Neoplasms, Glandular and Epithelial (5) · Head and Neck Neoplasms (4)
Capecitabine (1) · Carboplatin (1) · Educational Status (1) · Methods (1) · Nivolumab (1) · Paclitaxel (1) · Positron-Emission Tomography (1) · Radiosurgery (1) · STA 9090 (1) · Taxes (1) · Tomography, X-Ray Computed (1) · Vorinostat (1)
Case Comprehensive Cancer Center (1) · Emory University (1) · National Cancer Institute (NCI) (1) · Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University (1) · Wake Forest University Health Sciences (1)
United States (5) · Canada (1)
Chandylen Nightingale (1) · Eric Chen (1) · Jennifer Johnson, MD, PhD (1) · Nabil F. Saba, MD (1) · Shlomo Koyfman (1)
N01CM00032 (1), N01CM00038 (1), P30CA012197 (1), P30CA043703 (1), R03CA208560 (1)